Clinical Trial Update: Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US

View source ↗

Summary

This completed US study examines the partial response to proton pump inhibitors in gastroesophageal reflux disease and evaluates the societal costs and patient …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Proton Pump Inhibitors

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease (GERD) | Status: COMPLETED